FairJourney Bio Announces Scientific Program and Leadership for The Antibody Series 2026

Source Summary

PORTO, Portugal--(BUSINESS WIRE)--FairJourney Bio (“FJBio”), a global antibody discovery expert, has announced the program for The Antibody Series (TAS) 2026, which will explore how insights from natural antibody repertoires, advances in computational design, and novel engineering strategies are transforming the discovery and development of antibody therapeutics. Taking place in Évora, Portugal, September 16–18, the three-day forum will bring together leading scientists and industry voices to d